If Wegovy Stops Working, Here's What the Evidence Actually Shows

The biggest myth: a plateau means Wegovy has stopped working

Most people who search this question believe the medicine has simply run out of effect, like a painkiller wearing off. That framing is understandable but usually wrong. What Wegovy (semaglutide) does is reduce appetite and slow gastric emptying via GLP-1 receptor signalling; those mechanisms do not disappear. What changes, often between months four and twelve, is that your body reaches a new equilibrium. Calorie intake has fallen, but so has your resting metabolic rate, because your body weighs less and adapts accordingly. If you are concerned that Wegovy has stopped working for you, it helps to understand that the medicine is still doing its job, and that the arithmetic of energy balance has shifted around it.

The STEP 1 trial, published in the New England Journal of Medicine, recorded an average of around 15% body-weight reduction over 68 weeks at the 2.4mg maintenance dose. But that average conceals a wide spread: some participants plateaued earlier, some continued losing weight toward the end of the study. A plateau at week 20 is not the same event as true non-response at week 48. Understanding which situation you are in matters, which is why the first step is not changing the medicine, it is assessing what is actually happening.

If you want to understand the distinction more deeply, the page on whether Wegovy stops working over time covers the long-term evidence in more detail.

Four reasons Wegovy can feel like it has stopped, and how they differ

Not all plateaus have the same cause, and the response to each is different. The most common pattern is biological adaptation: as weight falls, the body defends a new set point by reducing metabolic rate and, sometimes, subtly increasing hunger signals. This is well-documented in obesity research and is not a flaw in the medicine. The second pattern is dose: if you are still on a lower step in the titration schedule, you may simply not yet be at the dose that achieves your individual maintenance response. Discuss this with your prescriber before assuming the treatment is done.

A third pattern (one that is easy to underestimate) is lifestyle drift. Wegovy suppresses appetite, but it does not remove the influence of food environment, stress eating, sleep, or physical activity. Over months, old habits can quietly reassert themselves without the person noticing. Research consistently shows that GLP-1 medicines work best alongside dietary and activity changes, not instead of them. The relationship between Wegovy and exercise is genuinely relevant here, not as a way to blame you but because the combination has a measurably stronger effect on body composition. Finally, adherence matters: a missed injection here and there, incorrect injection technique, or storage outside the recommended temperature range can all blunt the medicine's effect more than people expect.

Thinking through which of these applies to you is something the guide on what to do when semaglutide stops working addresses step by step.

How to tell whether it's a plateau or genuine non-response

There is a practical clinical threshold. The NICE recommendation for semaglutide (TA875) advises that clinicians consider stopping treatment if a patient has not achieved at least 5% weight loss after six months at the maintenance dose. That benchmark is a useful reference point even in private treatment. If you have been at 2.4mg for less than six months, or have not yet reached 2.4mg, the evidence does not yet support a conclusion that the treatment is not working for you.

Tracking is helpful here. If your weight has genuinely not moved in three or four months despite being at the right dose, that is different from a two-week stall after a holiday week. Keeping a simple record (weight at the same time each week, ideally first thing in the morning) gives your prescriber something concrete to work with. Our page on how to tell if Wegovy is working sets out what meaningful progress actually looks like across the treatment period, which can be more reassuring than the number on the scales on a given Tuesday.

If you are uncertain whether you are on the right track, our FAQs cover several related questions about treatment progress.

What genuinely to do if Wegovy stops working after full assessment

If a prescriber has confirmed you are at the correct dose, your lifestyle habits are consistent, and there has been no meaningful progress for six months, the options are real and worth discussing openly. For some people, the answer is a structured medication review: semaglutide suits most people but not everyone equally, and tirzepatide (which acts on both GIP and GLP-1 receptors rather than one) produced greater average weight loss than semaglutide 2.4mg in the SURMOUNT-5 head-to-head trial. That is not a reason to switch impulsively; it is a reason to have an informed conversation. You can read a broader overview of the clinical evidence around semaglutide and compare it with other treatment options before that conversation.

What is not the answer: stopping abruptly without a plan, or sourcing medicines through unverified sellers because a regulated route feels slow. Abrupt discontinuation typically leads to rapid weight regain, as documented in follow-up data from the STEP trials. The medicine was not keeping you at a lower weight through habit, it was doing active physiological work that your system cannot replicate without it.

A GPhC-registered prescriber at our pharmacy reviews each situation individually. There is no algorithm making that call. If you are at this point with your treatment, a conversation with a clinician is the right next step, not a forum post. Start your free consultation and our prescribers will review your situation the same day.